
|Articles|January 1, 2014
Supplements and Featured Publications
- Non-Small Cell Lung Cancer: Clinical and Economic Considerations in Targeting Therapy Based on Molec
- Volume 19
- Issue 19 Suppl
Post Test: Non-Small Cell Lung Cancer: Clinical and Economic Considerations in Targeting Therapy Based on Molecular Profiling
Advertisement
Instructions
After reading “Non-Small Cell Lung Cancer: Clinical and Economic Considerations in Targeting Therapy Based on Molecular Profiling,” complete the program evaluation and select the single best answer to each of the posttest questions.
A statement of continuing education credit will be provided to those physicians and pharmacists who successfully complete and return the answer form and program evaluation and receive a passing grade of 70% or higher on the posttest.
Articles in this issue
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Enlicitide, First Oral PCSK9 for High Cholesterol
2
Prior Cancer History Predicts Second Cancers in Polycythemia Vera, Essential Thrombocythemia
3
Hepatitis Prevention Programs Improve Liver Outcomes, but Gaps in Screening, Care Remain
4
SYNCHRONIZE-1 Through a Hepatologist's Lens: Liver Fat Reduction, Visceral Fat, and What Comes Next
5





